Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 70%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 61% · prior close shown (market closed)
Limited proprietary earnings coverage for HALO yet — signals will sharpen as filings and earnings are ingested.
Pipeline evidence · 32d ago
Reported figures for HALOZYME THERAPEUTICS, INC. — research only, not investment advice.
Updated
What happened recently for HALOZYME THERAPEUTICS, INC. (HALO) — events, not interpretation.
Research & analysis only — not investment advice.
Investment snapshot
Prior close
$98.66
Market cap
$11.20B
Profitable
Yes
Revenue $376.71M
Net income
$150.05M
FY Jul 17, 2026
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for HALOZYME THERAPEUTICS, INC. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Connected companies and research pages from the AlphaOS knowledge graph.
Follow HALOZYME THERAPEUTICS, INC. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.